InvestorsHub Logo
Followers 28
Posts 4995
Boards Moderated 0
Alias Born 01/07/2020

Re: Whalatane post# 241722

Friday, 01/17/2020 7:09:57 AM

Friday, January 17, 2020 7:09:57 AM

Post# of 424599
Wahl@

Ok - sleeping on it - i do' take your point about Reduce-It.

And of course - Amarin going for a market where just about everybody' - that would be a potential user of your drug - is on statins, what they did were the only realistic approach possible - to do the trial.

I have heard JT in presentations mention - that Vascepa is also aimed at people who are statin intolerant - so it is in the cards for Vascepa.
---------------------

I can get carried away in a (for me) new subject - and that is what happened in reading - seeing videos about cholesterol and statins.

And i do realize that a investing forum like this - might not be the place for this kind of debate - so I will leave at that for the future.

I did/do not feel especially neglected though - except maybe around the statin critic to your point.

jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News